Related Experiment Video
Updated: Feb 11, 2026

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
Conventional drug therapy for inflammatory bowel disease
Robert V Bryant1, Oliver Brain, Simon P L Travis
1Translational Gastroenterology Unit, Oxford University Hospitals Trust , Oxford , UK.
This review provides a practical guide to conventional therapies for inflammatory bowel diseases (IBD), covering drug efficacy and safety. It focuses on established treatments like aminosalicylates and biologics for better patient management.
Area of Science:
- Gastroenterology and Hepatology
- Clinical Pharmacology
Background:
- Conventional medical therapy remains the primary treatment for most inflammatory bowel diseases (IBD) patients.
- Emerging IBD therapies are often restricted by healthcare regulations and availability at specialized centers.
Purpose of the Study:
- To offer a pragmatic approach to conventional IBD therapy based on current evidence.
- To guide optimal and appropriate clinical practice for managing IBD.
Main Methods:
- Systematic review of current evidence on conventional IBD therapies.
- Analysis of drug efficacy, safety profiles, and practice points.
Main Results:
- Conventional therapies discussed include aminosalicylates, corticosteroids, thiopurines, methotrexate, calcineurin inhibitors, infliximab, and adalimumab.
- Key considerations for efficacy, safety, and practical application are addressed for each agent.
Conclusions:
- This review synthesizes evidence to support practical decision-making in conventional IBD treatment.
- Optimal use of established therapies is crucial for effective and safe management of inflammatory bowel diseases.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drug Therapy
Antianxiety Medications

